Abstract
Quality improvement efforts have focused on reducing interstage mortality for infants with hypoplastic left heart syndrome (HLHS). In 1/2016, two publications reported that use of digoxin was associated with reduced interstage mortality. The degree to which these findings have affected real world practice has not been evaluated. The discharge medications of neonates with HLHS undergoing Norwood operation between 1/2007 and 12/2018 at Pediatric Health Information Systems Database hospitals were studied. Mixed effects models were calculated to evaluate the hypothesis that the likelihood of digoxin prescription increased after 1/2016, adjusting for measurable confounders with furosemide and aspirin prescription measured as falsification tests. Interhospital practice variation was measured using the median odds ratio. Over the study period, 6091 subjects from 45 hospitals were included. After adjusting for measurable covariates, discharge after 1/2016 was associated with increased odds of receiving digoxin (OR 3.9, p < 0.001). No association was seen between date of discharge and furosemide (p = 0.26) or aspirin (p = 0.12). Prior to 1/2016, the likelihood of receiving digoxin was decreasing (OR 0.9 per year, p < 0.001), while after 1/2016 the rate has increased (OR 1.4 per year, p < 0.001). However, there remains significant interhospital variation in the likelihood of receiving digoxin even after adjusting for known confounders (median odds ratio = 3.5, p < 0.0001). Following publication of studies describing an association between digoxin and improved interstage survival, the likelihood of receiving digoxin at discharge increased without similar changes for furosemide or aspirin. Despite concerted efforts to standardize interstage care, interhospital variation in pharmacotherapy in this vulnerable population persists.
Similar content being viewed by others
Data Availability
The data analyzed are proprietary and cannot be shared under the conditions of our data use agreement. Analytic code will be shared on request provided the requestor pledges that it will be used for academic purposes and appropriate citation is applied.
References
Alsoufi B, McCracken C, Kochilas LK, Clabby M, Kanter K (2018) Factors associated with interstage mortality following neonatal single ventricle palliation. World J Pediatr Congenit Heart Surg 9:616–623
Hansen JH, Furck AK, Petko C, Buchholz-Berdau R, Voges I, Scheewe J, Rickers C, Kramer H-H (2012) Use of surveillance criteria reduces interstage mortality after the Norwood operation for hypoplastic left heart syndrome. Eur J Cardiothorac Surg 41:1013–1018
Ghanayem NS, Hoffman GM, Mussatto KA, Cava JR, Frommelt PC, Rudd NA, Steltzer MM, Bevandic SM, Frisbee SS, Jaquiss RDB, Litwin SB, Tweddell JS (2003) Home surveillance program prevents interstage mortality after the Norwood procedure. J Thorac Cardiovasc Surg 126:1367–1377
Castellanos DA, Herrington C, Adler S, Haas K, Ram Kumar S, Kung GC (2016) Home monitoring program reduces mortality in high-risk sociodemographic single-ventricle patients. Pediatr Cardiol 37:1575–1580
Furck AK, Uebing A, Hansen JH, Scheewe J, Jung O, Fischer G, Rickers C, Holland-Letz T, Kramer H-H (2010) Outcome of the Norwood operation in patients with hypoplastic left heart syndrome: a 12-year single-center survey. J Thorac Cardiovasc Surg 139:359–365
Gardner MM, Mercer-Rosa L, Faerber J, DiLorenzo MP, Bates KE, Stagg A, Natarajan SS, Szwast A, Fuller S, Mascio CE, Fleck D, Torowicz DL, Giglia TM, Rome JJ, Ravishankar C (2019) Association of a home monitoring program with interstage and stage 2 outcomes. J Am Heart Assoc 8:e010783
Hehir DA, Dominguez TE, Ballweg JA, Ravishankar C, Marino BS, Bird GL, Nicolson SC, Spray TL, Gaynor JW, Tabbutt S (2008) Risk factors for interstage death after Stage 1 reconstruction of hypoplastic left heart syndrome and variants. J Thorac Cardiovasc Surg 136:94–9–99.e1–3
Petit CJ, Fraser CD, Mattamal R, Slesnick TC, Cephus CE, Ocampo EC (2011) The impact of a dedicated single-ventricle home-monitoring program on interstage somatic growth, interstage attrition, and 1-year survival. J Thorac Cardiovasc Surg 142:1358–1366
Simsic JM, Bradley SM, Stroud MR, Atz AM (2005) Risk factors for interstage death after the Norwood procedure. Pediatr Cardiol 26:400–403
Taylor LC, Burke B, Donohue JE, Yu S, Hirsch-Romano JC, Ohye RG, Goldberg CS (2016) Risk factors for interstage mortality following the Norwood procedure: impact of sociodemographic factors. Pediatr Cardiol 37:68–75
Rudd NA, Frommelt MA, Tweddell JS, Hehir DA, Mussatto KA, Frontier KD, Slicker JA, Bartz PJ, Ghanayem NS (2014) Improving interstage survival after Norwood operation: outcomes from 10 years of home monitoring. J Thorac Cardiovasc Surg 148:1540–1547
Clauss SB, Anderson JB, Lannon C, Lihn S, Beekman RH, Kugler JD, Martin GR (2015) Quality improvement through collaboration: the National Pediatric Quality improvement Collaborative initiative. Curr Opin Pediatr 27:555–562
Anderson JB, Beekman RH, Kugler JD, Rosenthal GL, Jenkins KJ, Klitzner TS, Martin GR, Neish SR, Brown DW, Mangeot C, King E, Peterson LE, Provost L, Lannon C, National Pediatric Cardiology Quality Improvement Collaborative (2015) Improvement in interstage survival in a National Pediatric Cardiology Learning Network. Circ Cardiovasc Qual Outcomes 8:428–436
Brown DW, Mangeot C, Anderson JB, Peterson LE, King EC, Lihn SL, Neish SR, Fleishman C, Phelps C, Hanke S, Beekman RH III, Lannon CM, The National Pediatric Cardiology Quality Improvement Collaborative (2016) Digoxin use is associated with reduced interstage mortality in patients with no history of arrhythmia after Stage I palliation for single ventricle heart disease. J Am Heart Assoc 5:85–88
Oster ME, Kelleman M, McCracken C, Ohye RG, Mahle WT (2016) Association of digoxin with interstage mortality: results from the Pediatric Heart Network single ventricle reconstruction trial public use dataset. J Am Heart Assoc 5:I82
Ghelani SJ, Spurney CF, Martin GR, Cross RR (2013) Impact of pharmacotherapy on interstage mortality and weight gain in children with single ventricle. Congenit Heart Dis 8:219–227
Truong DT, Menon SC, Lambert LM, Burch PT, Sheng X, Minich LL, Williams RV (2018) Digoxin use in infants with single ventricle physiology. Pediatr Cardiol 39:1200–1209
Ahmed H, Anderson JB, Bates KE, Fleishman CE, Natarajan S, Ghanayem NS, Sleeper LA, Lannon CM, Brown DW, National Pediatric Cardiology Quality Improvement Collaborative (2019) Development of a validated risk score for interstage death or transplant after Stage I palliation for single-ventricle heart disease. J Thorac Cardiovasc Surg 160(4):1021–1030
Feudtner C, Hays RM, Haynes G, Geyer JR, Neff JM (2001) Deaths attributed to pediatric complex chronic conditions: national trends and implications for supportive care services. Pediatrics 107:1–5
Sun G-W, Shook TL, Kay GL (1996) Inappropriate use of bivariable analysis to screen risk factors for use in multivariable analysis. J Clin Epidemiol 49:907–916
Hira RS, Kennedy K, Jneid H, Alam M, Basra SS, Petersen LA, Ballantyne CM, Nambi V, Chan PS, Virani SS (2014) Frequency and practice-level variation in inappropriate and nonrecommended prasugrel prescribing: insights from the NCDR PINNACLE Registry. J Am Coll Cardiol 63:2876–2877
Chan PS, Maddox TM, Tang F, Spinler S, Spertus JA (2011) Practice-level variation in warfarin use among outpatients with atrial fibrillation (from the NCDR PINNACLE program). Am J Cardiol 108:1136–1140
Maddox TM, Chan PS, Spertus JA, Tang F, Jones P, Ho PM, Bradley SM, Tsai TT, Bhatt DL, Peterson PN (2014) Variations in coronary artery disease secondary prevention prescriptions among outpatient cardiology practices: insights from the NCDR (National Cardiovascular Data Registry). J Am Coll Cardiol 63:539–546
Peterson PN, Chan PS, Spertus JA, Tang F, Jones PG, Ezekowitz JA, Allen LA, Masoudi FA, Maddox TM (2013) Practice-level variation in use of recommended medications among outpatients with heart failure: insights from the NCDR PINNACLE Program. Circ Heart Fail 6:1132–1138
O’Byrne ML, Shinohara RT, Grant EK, Kanter JP, Gillespie MJ, Dori Y, Rome JJ, Glatz AC (2017) Increasing propensity to pursue operative closure of atrial septal defects following changes in the instructions for use of the Amplatzer Septal Occluder device: an observational study using data from the Pediatric Health Information Systems Database. Am Heart J 192:85–97
O’Byrne ML, Kennedy KF, Rome JJ, Glatz AC (2018) Variation in practice patterns in device closure of atrial septal defects and patent ductus arteriosus: an analysis of data from the IMproving Pediatric and Adult Congenital Treatment (IMPACT) Registry. Am Heart J 196:119–130
Glatz AC, Kennedy KF, Rome JJ, O’Byrne ML (2018) Variations in practice patterns and consistency with published guidelines for balloon aortic and pulmonary valvuloplasty. JACC Cardiovasc Interv 11:529–538
O’Byrne ML, Glatz AC, Mercer-Rosa L, Gillespie MJ, Dori Y, Goldmuntz E, Kawut S, Rome JJ (2015) Trends in pulmonary valve replacement in children and adults with Tetralogy of Fallot. Am J Cardiol 115:118–124. http://linkinghub.elsevier.com/retrieve/pii/S0002914914019389
O’Byrne ML, Millenson ME, Grady CB, Huang J, Bamat NA, Munson DA, Song L, Dori Y, Gillespie MJ, Rome JJ, Glatz AC (2019) Trends in transcatheter and operative closure of patent ductus arteriosus in neonatal intensive care units. Am Heart J 217:121–130
Larsen K, Merlo J (2005) Appropriate assessment of neighborhood effects on individual health: integrating random and fixed effects in multilevel logistic regression. Am J Epidemiol 161:81–88
Jayaram N, Spertus JA, O’Byrne ML, Chan PS, Kennedy KF, Bergersen L, Glatz AC (2017) Relationship between hospital procedure volume and complications following congenital cardiac catheterization: a report from the IMproving Pediatric and Adult Congenital Treatment (IMPACT) Registry. Am Heart J 183:118–128
O’Byrne ML, Glatz AC, Shinohara RT, Jayaram N, Gillespie MJ, Dori Y, Rome JJ, Kawut S (2015) Effect of center catheterization volume on risk of catastrophic adverse event after cardiac catheterization in children. Am Heart J 169(823–832):e5
O’Byrne ML, Glatz AC, Song L, Griffis HM, Millenson ME, Gillespie MJ, Dori Y, DeWitt AG, Mascio CE, Rome JJ (2018) Association between variation in preoperative care before arterial switch operation and outcomes in patients with transposition of the great arteries. Circulation 138:2119–2129
O’Byrne ML, Gillespie MJ, Shinohara RT, Dori Y, Rome JJ, Glatz AC (2016) Cost comparison of transcatheter and operative pulmonary valve replacement (from the Pediatric Health Information Systems Database). Am J Cardiol 117:121–126
O’Byrne ML, Glatz AC, Faerber JA, Seshadri R, Millenson ME, Mi L, Shinohara RT, Dori Y, Gillespie MJ, Rome JJ, Kawut SM, Groeneveld PW (2019) Interhospital variation in the costs of pediatric/congenital cardiac catheterization laboratory procedures: analysis of data from the Pediatric Health Information Systems Database. J Am Heart Assoc 8:e011543. http://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&id=31023121&retmode=ref&cmd=prlinks
O’Byrne ML, Glatz AC, Hanna BD, Shinohara RT, Gillespie MJ, Dori Y, Rome JJ, Kawut SM (2015) Predictors of catastrophic adverse outcomes in children with pulmonary hypertension undergoing cardiac catheterization: a multi-institutional analysis from the Pediatric Health Information Systems Database. J Am Coll Cardiol 66:1261–1269
Mascio CE, Irons ML, Ittenbach RF, Gaynor JW, Fuller SM, Kaplinski M, Kennedy AT, Steven JM, Nicolson SC, Spray TL (2019) Thirty years and 1663 consecutive Norwood procedures: has survival plateaued? J Thorac Cardiovasc Surg 158:220–229
Poh CL, d’Udekem Y (2018) Life after surviving Fontan surgery: a meta-analysis of the incidence and predictors of late death. Heart Lung Circ 27:552–559
Allen KY, Downing TE, Glatz AC, Rogers LS, Ravishankar C, Rychik J, Fuller S, Montenegro LM, Steven JM, Spray TL, Nicolson SC, Gaynor JW, Goldberg DJ (2017) Effect of Fontan-associated morbidities on survival with intact Fontan circulation. Am J Cardiol 119:1866–1871
Newburger JW, Sleeper LA, Frommelt PC, Pearson GD, Mahle WT, Chen S, Dunbar-Masterson C, Mital S, Williams IA, Ghanayem NS, Goldberg CS, Jacobs JP, Krawczeski CD, Lewis AB, Pasquali SK, Pizarro C, Gruber PJ, Atz AM, Khaikin S, Gaynor JW, Ohye RG, Pediatric Heart Network Investigators (2014) Transplantation-free survival and interventions at 3 years in the single ventricle reconstruction trial. Circulation 129:2013–2020
Cao JY, Phan K, Ayer J, Celermajer DS, Winlaw DS (2018) Long term survival of hypoplastic left heart syndrome infants: meta-analysis comparing outcomes from the modified Blalock-Taussig shunt and the right ventricle to pulmonary artery shunt. Int J Cardiol 254:107–116
Menon SC, Keenan HT, Weng HYC, Lambert LM, Burch PT, Edwards R, Spackman A, Korgenski KE, Tani LY (2012) Outcome and resource utilization of infants born with hypoplastic left heart syndrome in the Intermountain West. Am J Cardiol 110:720–727
Keren R, Luan X, Localio R, Hall M, McLeod L, Dai D, Srivastava R, Pediatric Research in Inpatient Settings (PRIS) Network (2012) Prioritization of comparative effectiveness research topics in hospital pediatrics. Arch Pediatr Adolesc Med 166:1155–1164
Cross RR, Harahsheh AS, McCarter R, Martin GR, National Pediatric Cardiology Quality Improvement Collaborative (2014) Identified mortality risk factors associated with presentation, initial hospitalisation, and interstage period for the Norwood operation in a multi-centre registry. Cardiol Young 24:253–262
Van Hare GF (2019) Perspective. Digoxin for interstage single ventricle patients: what could possibly go wrong? Congenit Heart Dis 14:321–323
Brown KL, Crowe S, Franklin R, McLean A, Cunningham D, Barron D, Tsang V, Pagel C, Utley M (2015) Trends in 30-day mortality rate and case mix for paediatric cardiac surgery in the UK between 2000 and 2010. Open Heart 2:e000157
Funding
Dr. O’Byrne (K23 HL130420-01) receives funding from the National Heart Lung and Blood Institute. The funding agency had no role in the planning or execution of the study, nor did they edit the manuscript as presented. The manuscript represents the opinions of the authors alone.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
No financial conflicts of interest to disclose.
Ethical Approval
The manuscript describes an analysis of a de-identified administrative dataset. The Institutional Review Board at our institution has ruled that all analyses from this database are exempt from review.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Supplementary Information
Below is the link to the electronic supplementary material.
Rights and permissions
About this article
Cite this article
O’Byrne, M.L., Song, L., Huang, J. et al. Trends in Discharge Prescription of Digoxin After Norwood Operation: An Analysis of Data from the Pediatric Health Information System (PHIS) Database. Pediatr Cardiol 42, 793–803 (2021). https://doi.org/10.1007/s00246-021-02543-y
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s00246-021-02543-y